Bright Light Therapy as Possible Treatment Option for Fatigue in Multiple Sclerosis Patients - A Randomised Controlled Trial

Status unknownNot a drug-phase studyMS (type not specified)NCT04681586

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • bright light therapy

Placebo

  • dim red light

What it measured

Main measures

  • Change in fatigue levels

    Day 1, Day 14, Day 30, Day 46

    Fatigue
  • Change in fatigue levels

    Day 15, Day 31

    Fatigue

Who could take part

MS (type not specified) · 18 to 65

Show the full criteria

Inclusion criteria

* MS patients who suffer from fatigue * Age between 18 and 65 years old * FSS Score of 36 or greater * ESS Score of 12 or greater * MEQ Score between 31 and 69 * BDI Score lower than 19 * BAI Score lower than 27 * EDSS lower than 4

Exclusion criteria

* sleep disorders (periodic limb movement disorders, obstructive or central sleep apnea, REM sleep behavior disorders) * change of antidepressive/fatigue influencing/sleep influencing/photosensizing/MS medication within the preceding 4 weeks * clinical MS-relapse within the preceding 4 weeks * consumption of alcohol: more than 1 glass per day * consumption of caffeine: more than 4 cups per day * current shift work * Jet lag (travelled across two or more time zones within 90 days before study screening * Retinopathy or other visual diseases/abnormalties * Traumatic brain injury within the preceding 5 years * pregnant or lactating * Participation in another clinical trial at the same time

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This study aims to investigate the effect of a 2-week trial of bright light therapy (BLT, 10.000 lx) on fatigue in multiple sclerosis (MS) patients. In this randomised placebo-controlled trial, the effect of bright light therapy will be compared to dim red light. MS-fatigue is quantified by patients using a visual analogue scale (VAS) and activity levels, subjective and objective sleep parameters and daytime sleepiness are measured.

Papers

    Loading reviews and guidelines…

    History

      1. Started

        Dec 2019

      2. Main results due

        Sept 2021

      3. Finished

        Jan 2022

      Assembled by software from public sources.